HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

11-amino-N-propylnoraporphine

an antiparkinsonian agent that is an agonist of both dopamine D2 receptors and 5-HT(1A) serotonin receptors; structure in first source

Also Known As:

SOMCL-171

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Benzylisoquinolines: 151
    - Aporphines: 10
      - 11-amino-N-propylnoraporphine: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoquinolines: 34
      - Benzylisoquinolines: 151
        Aporphines: 10
        11-amino-N-propylnoraporphine: 1
  - 4 or More Rings Heterocyclic Compounds
    - Aporphines: 10
      - 11-amino-N-propylnoraporphine: 1

Experts

1.	Fang, Xing: 1 article (09/2014)
2.	Guo, Lin: 1 article (09/2014)
3.	Jia, Jia: 1 article (09/2014)
4.	Liu, Zhili: 1 article (09/2014)
5.	Lu, Weijian: 1 article (09/2014)
6.	Yang, Zhi: 1 article (09/2014)
7.	Ye, Na: 1 article (09/2014)
8.	Zhang, Ao: 1 article (09/2014)
9.	Zhao, Bin: 1 article (09/2014)
10.	Zhao, Jiahao: 1 article (09/2014)

Related Diseases

1.	Dyskinesias (Dyskinesia) 09/01/2014 - "The present data indicated that chronic SOMCL-171 alone produced potent antiparkinsonian effects with weak dyskinesia, compared with that of levodopa. "

Related Drugs and Biologics

1.	Levodopa (L Dopa)